Procter & Gamble Tops Q2 EPS on $22.21B Revenue as GDS Wealth Boosts Stake 20.9%

PGPG

GDS Wealth boosted its Q3 stake in Procter & Gamble by 20.9% to 81,190 shares valued at $12.48 million, while Cullen Frost and Commerzbank cut positions by 13.1% and 8.0%. The company beat Q2 forecasts with $1.88 EPS on $22.21 billion revenue (+1.5% YoY), seeing JPMorgan and UBS raise targets to $165 and $170.

1. Procter & Gamble Validates Long‐Term Floor

After the company’s latest quarterly report, shares of Procter & Gamble are trading at levels not seen in over a decade, suggesting the market has priced in the lowest‐case scenario of tepid organic sales growth. Despite only a 1.5% year‐over‐year revenue increase to $22.21 billion in the most recent quarter, P&G posted $1.88 in adjusted EPS, edging analysts’ consensus by $0.02. Operating margins held steady at 24.8%, supporting a return on equity of 32.1%. Management reiterated full‐year EPS guidance in the range of 6.83 to 7.09, underscoring the company’s ability to generate free cash flow sufficient to maintain and potentially raise its quarterly dividend, currently annualized at $4.23 per share. Institutional ownership remains robust at roughly 66%, signaling continued confidence among large investors in P&G’s capacity to compound shareholder returns over the next economic cycle.

2. Institutional Investors Lift Stakes in Third Quarter Filings

GDS Wealth Management increased its position in Procter & Gamble by 20.9% during the third quarter, acquiring an additional 14,060 shares and bringing its total to 81,190 shares, valued at approximately $12.48 million at quarter‐end. BAM Wealth Management initiated a new stake of $678,000, while Acorn Wealth Advisors added 173 shares to reach 4,028 shares. PFG Investments and Symphony Financial each boosted holdings by 1.6% and 1.9%, respectively, lifting their stakes to 54,237 and 13,771 shares. Inlet Private Wealth added 172 shares to reach 11,265 shares. Collectively, these moves reflect a broader trend of portfolio managers rotating into defensive, cash‐generative names with sustainable dividend yields in the low‐to‐mid 2% range. The shift reinforces P&G’s reputation as a cornerstone holding in consumer staples allocations.

3. Analysts Raise Targets on Consistent Cash Generation

Several research firms have adjusted their ratings following P&G’s stable performance. JPMorgan Chase upgraded the name to overweight and lifted its 12‐month target from $157 to $165, citing resilience in pricing and mix optimization. UBS increased its target from $161 to $170, highlighting potential margin expansion in Fabric & Home Care. Piper Sandler, after initiating coverage with a neutral rating, set a target of $150, noting valuation near cycle lows. Raymond James trimmed its target from $185 to $175 but maintained an outperform rating, pointing to reliable dividend growth backed by a 62.7% payout ratio. The consensus among 22 analysts remains a Moderate Buy, with an average target of $166.70.

4. Dividend Safety and Capital Allocation

P&G declared a quarterly dividend of $1.0568 per share, payable February 17, to holders of record January 23. The payout ratio sits at 62.7%, below its historical ceiling of 70%, leaving room for future increases. Over the past five years, P&G has delivered a 9.3% compound annual dividend growth rate. Management’s focus on share repurchases continues, with $5.5 billion returned to shareholders in the past four quarters. Balance sheet strength—debt‐to‐equity at 0.48 and a current ratio of 0.72—supports investment in high‐return categories and M&A to sustain long‐term compounding rates above 8%. Investors seeking income stability and modest growth view this allocation strategy as a key catalyst for the stock’s next leg of total return.

Sources

MDDDD